Cite
Life threatening liver disease during treatment with monoclonal antibodies.
MLA
Kaiser, Thorsten, et al. “Life Threatening Liver Disease during Treatment with Monoclonal Antibodies.” BMJ (Clinical Research Ed.), vol. 338, Feb. 2009, p. b508. EBSCOhost, https://doi.org/10.1136/bmj.b508.
APA
Kaiser, T., Moessner, J., Patel, K., McHutchison, J. G., & Tillmann, H. L. (2009). Life threatening liver disease during treatment with monoclonal antibodies. BMJ (Clinical Research Ed.), 338, b508. https://doi.org/10.1136/bmj.b508
Chicago
Kaiser, Thorsten, Joachim Moessner, Keyur Patel, John G McHutchison, and Hans L Tillmann. 2009. “Life Threatening Liver Disease during Treatment with Monoclonal Antibodies.” BMJ (Clinical Research Ed.) 338 (February): b508. doi:10.1136/bmj.b508.